Last $0.06 USD
Change Today +0.01 / 20.00%
Volume 82.0K
VODG On Other Exchanges
Symbol
Exchange
OTC US
As of 5:20 PM 05/22/13 All times are local (Market data is delayed by at least 15 minutes).

vitro diagnostics inc (VODG) Snapshot

Open
$0.05
Previous Close
$0.05
Day High
$0.06
Day Low
$0.05
52 Week High
02/25/13 - $0.15
52 Week Low
12/7/12 - $0.02
Market Cap
1.2M
Average Volume 10 Days
9.2K
EPS TTM
--
Shares Outstanding
19.3M
EX-Date
04/24/89
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for VITRO DIAGNOSTICS INC (VODG)

Related News

No related news articles were found.

vitro diagnostics inc (VODG) Related Businessweek News

No Related Businessweek News Found

vitro diagnostics inc (VODG) Details

Vitro Diagnostics, Inc., doing business as Vitro Biopharma, focuses on the development, manufacture, and distribution of stem cell products and related tools for use in research and drug discovery. Its stem cell technology includes cell lines, supporting products, and methods for generation and differentiation of stem cells into products with applications to treatment of various diseases, such as heart disease, stroke, Parkinson’s, and Alzheimer’s diseases. The company also develops and sells ‘Tools for Stem Cell and Drug Development’ that offers researchers basic tools needed to advance stem cell technology, including stem cells and their derivatives, media for growth and differentiation of stem cells, and tools for measurement of stem cell quality, potency, and response to toxic agents. In addition, it offers VITROPIN, a purified urinary follicle-stimulating hormone (FSH) preparation; and Cell Line-Derived FSH for immortalization of pituitary cells known as gonadotropes that synthesize and secrete FSH and LH. Further, the company provides fluorescent labeled stem cells, using various specific labels to enhance utility for various applications in stem cell research. It has a strategic alliance with HemoGenix, Inc. to develop products for the determination of stem cell quality, potency, and response to toxic agents. Vitro Diagnostics, Inc. was founded in 1986 and is based in Golden, Colorado.

1 Employees
Last Reported Date: 02/12/13
Founded in 1986

vitro diagnostics inc (VODG) Top Compensated Officers

Chairman, Chief Executive Officer, President,...
Total Annual Compensation: $12.0K
Compensation as of Fiscal Year 2012.

vitro diagnostics inc (VODG) Key Developments

Vitro Diagnostics, Inc. announced delayed 10-Q filing

On 03/18/2013, Vitro Diagnostics, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Vitro Diagnostics Announces Board Changes

Vitro Diagnostics, Inc. accepted the resignation of Mr. Erik Van Horn from its Board of Directors and appointed Pete Shuster, the CEO of Neuromics, Inc. to its Board of Directors. Mr. Shuster is a seasoned and experienced sales executive. He is the current owner of Neuromics, Inc.

Vitro Diagnostics, Inc. Auditor Raises 'Going Concern' Doubt

Vitro Diagnostics, Inc. filed its 10-K on Feb 12, 2013 for the period ending Oct 31, 2012. In this report its auditor, Schumacher & Associates, Inc, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VODG:US $0.06 USD +0.01

VODG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Life Technologies Corp $74.10 USD +0.42
Lonza Group AG SFr.74.90 CHF +0.80
View Industry Companies
 

Industry Analysis

VODG

Industry Average

Valuation VODG Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 25.0x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 8.2x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VITRO DIAGNOSTICS INC, please visit www.vitrobiopharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.